Evaluation of self-initiated humour protocol

A randomised control trial to evaluate the efficacy of digital self-initiated humour protocol on sub-clinical population

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN39859529

Enrollment

Registered

2025-03-04

Start date

2025-03-14

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotional well-being Mental and Behavioural Disorders

Interventions

Pre-Intervention Phase: We will begin with organising a Q&A session for potential volunteers to learn more about the study. Interested volunteers can submit their interest by completing the Trial cons

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Adults (aged 18 years and above) 2. Fluent in the English language 3. Have a good-quality childhood photo 4. PHQ-9 score less than 15 (excluding moderately severe depression and anxiety) and above 4. 5. GAD-7 score less than 15 (excluding moderately severe depression and anxiety) and above 4

Exclusion criteria

Exclusion criteria: 1. Any history of organic brain disease such as dementia, MS and Parkinson's disease 2. Substance abuse (drug or alcohol) 3. Have recently started (within 3 months) or planning to start some other psychological intervention or psychiatric medication. 4. Any suicidal ideation (as measured by PHQ-9 Q9)

Design outcomes

Primary

Measure	Time frame
Wellbeing measured using the PERMA Profiler immediately prior to the intervention (groups 1 & 2), at 8 weeks (groups 1 & 2), 16 weeks (group 2), 24 weeks (group 2), 30 weeks (group 1), 38 weeks (group 2)	—

Secondary

Measure	Time frame
Measured immediately prior to the intervention (groups 1 & 2), at 8 weeks (groups 1 & 2), 16 weeks (group 2), 24 weeks (group 2), 30 weeks (group 1), 38 weeks (group 2): 1. Depression measured using the Patient Health Questionnaire-9 (PHQ-9) 2. Anxiety measured using the Generalised Anxiety Disorder-7 (GAD-7) 3. Self-compassion measured using the Sussex-Oxford Compassion for the Self Scale (SOCS-S) 4. Compassion measured using the Compassion Scale 5. Emotional self-regulation measured using the Emotion Regulation Questionnaire (ERQ) 6. Humour styles measured using the Humour Styles Questionnaire (HSQ) 7. Psychological capital measured using the Revised Compound Psychological Capital scale (CPC-12R)	—

Measure

Time frame

Measured immediately prior to the intervention (groups 1 & 2), at 8 weeks (groups 1 & 2), 16 weeks (group 2), 24 weeks (group 2), 30 weeks (group 1), 38 weeks (group 2): 1. Depression measured using the Patient Health Questionnaire-9 (PHQ-9) 2. Anxiety measured using the Generalised Anxiety Disorder-7 (GAD-7) 3. Self-compassion measured using the Sussex-Oxford Compassion for the Self Scale (SOCS-S) 4. Compassion measured using the Compassion Scale 5. Emotional self-regulation measured using the Emotion Regulation Questionnaire (ERQ) 6. Humour styles measured using the Humour Styles Questionnaire (HSQ) 7. Psychological capital measured using the Revised Compound Psychological Capital scale (CPC-12R)

—

Countries

Australia, Canada, China, Denmark, Egypt, England, France, Germany, India, Iran, Italy, Lebanon, Pakistan, Singapore, Spain, Sweden, United Kingdom, United States of America

Contacts

Public ContactAbbas Edalat

ae@ic.ac.uk+44 (0)2075948245

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026